Avacta Group plc is a biopharmaceutical company that develops Affimer technology, a proprietary platform for the discovery and development of novel therapeutics and diagnostic tools. The company focuses on creating innovative solutions in immunotherapy, targeting cancer treatment, and providing critical tools for research in various fields.